Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Schuster

Showing results (31-40 of 173) with videos related to

Pageof 18
Sort By:
Proceedings of Spie--The International Society for Optical Engineering|June 19, 2012
A Molecular Image-directed, 3D Ultrasound-guided Biopsy System for the ProstateBaowei Fei, David M Schuster, Viraj Master, et al.
Journal of Nuclear Medicine Technology|October 13, 2019
Characterizing and Mitigating Bladder Radioactivity on <sup>18</sup>F-Fluciclovine PET/CTPetra Lovrec, David M Schuster, Robert H Wagner, et al.
International Journal of Molecular Sciences|May 5, 2017
Fasting Enhances the Contrast of Bone Metastatic Lesions in <sup>18</sup>F-Fluciclovine-PET: Preclinical Study Using a Rat Model of Mixed Osteolytic/Osteoblastic Bone MetastasesShuntaro Oka, Masaru Kanagawa, Yoshihiro Doi, et al.
Clinical Nuclear Medicine|December 14, 2020
Ring Sclerosis in Prostate Cancer: Circle of Malignancy or Benignity?Charles Marcus, Yoram Baum, Olayinka A Abiodun-Ojo, et al.
Theranostics|June 29, 2017
PET Tracer <sup>18</sup>F-Fluciclovine Can Detect Histologically Proven Bone Metastatic Lesions: A Preclinical Study in Rat Osteolytic and Osteoblastic Bone Metastasis ModelsShuntaro Oka, Masaru Kanagawa, Yoshihiro Doi, et al.
Medicinal Research Reviews|July 28, 2011
Radiohalogenated nonnatural amino acids as PET and SPECT tumor imaging agentsJonathan McConathy, Weiping Yu, Nachwa Jarkas, et al.
Nuclear Medicine and Biology|October 1, 2011
Transport mechanisms of trans-1-amino-3-fluoro[1-(14)C]cyclobutanecarboxylic acid in prostate cancer cellsShuntaro Oka, Hiroyuki Okudaira, Yasunori Yoshida, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 24, 2022
Predictors and Real-World Use of Prostate-Specific Radioligand Therapy: PSMA and BeyondAndrei Gafita, Charles Marcus, Louise Kostos, et al.
Nuclear Medicine and Biology|February 16, 2018
<sup>90</sup>Y radioembolization dosimetry using a simple semi-quantitative method in intrahepatic cholangiocarcinoma: Glass versus resin microspheresNariman Nezami, Nima Kokabi, Juan C Camacho, et al.
Clinical Nuclear Medicine|July 24, 2020
Incidental Detection of Lung Adenocarcinoma Presenting as an Anterior Mediastinal Mass on 18F-Fluciclovine PET/CT in a Patient With Primary Prostate CancerOlayinka A Abiodun-Ojo, Akinyemi A Akintayo, Gabriel L Sica, et al.
Pageof 18

Showing results (31-40 of 173) with videos related to

Sort By:
Pageof 18
Proceedings of Spie--The International Society for Optical Engineering|June 19, 2012
A Molecular Image-directed, 3D Ultrasound-guided Biopsy System for the ProstateBaowei Fei, David M Schuster, Viraj Master, et al.
Journal of Nuclear Medicine Technology|October 13, 2019
Characterizing and Mitigating Bladder Radioactivity on <sup>18</sup>F-Fluciclovine PET/CTPetra Lovrec, David M Schuster, Robert H Wagner, et al.
International Journal of Molecular Sciences|May 5, 2017
Fasting Enhances the Contrast of Bone Metastatic Lesions in <sup>18</sup>F-Fluciclovine-PET: Preclinical Study Using a Rat Model of Mixed Osteolytic/Osteoblastic Bone MetastasesShuntaro Oka, Masaru Kanagawa, Yoshihiro Doi, et al.
Clinical Nuclear Medicine|December 14, 2020
Ring Sclerosis in Prostate Cancer: Circle of Malignancy or Benignity?Charles Marcus, Yoram Baum, Olayinka A Abiodun-Ojo, et al.
Theranostics|June 29, 2017
PET Tracer <sup>18</sup>F-Fluciclovine Can Detect Histologically Proven Bone Metastatic Lesions: A Preclinical Study in Rat Osteolytic and Osteoblastic Bone Metastasis ModelsShuntaro Oka, Masaru Kanagawa, Yoshihiro Doi, et al.
Medicinal Research Reviews|July 28, 2011
Radiohalogenated nonnatural amino acids as PET and SPECT tumor imaging agentsJonathan McConathy, Weiping Yu, Nachwa Jarkas, et al.
Nuclear Medicine and Biology|October 1, 2011
Transport mechanisms of trans-1-amino-3-fluoro[1-(14)C]cyclobutanecarboxylic acid in prostate cancer cellsShuntaro Oka, Hiroyuki Okudaira, Yasunori Yoshida, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 24, 2022
Predictors and Real-World Use of Prostate-Specific Radioligand Therapy: PSMA and BeyondAndrei Gafita, Charles Marcus, Louise Kostos, et al.
Nuclear Medicine and Biology|February 16, 2018
<sup>90</sup>Y radioembolization dosimetry using a simple semi-quantitative method in intrahepatic cholangiocarcinoma: Glass versus resin microspheresNariman Nezami, Nima Kokabi, Juan C Camacho, et al.
Clinical Nuclear Medicine|July 24, 2020
Incidental Detection of Lung Adenocarcinoma Presenting as an Anterior Mediastinal Mass on 18F-Fluciclovine PET/CT in a Patient With Primary Prostate CancerOlayinka A Abiodun-Ojo, Akinyemi A Akintayo, Gabriel L Sica, et al.
Pageof 18